Stay updated on PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now shows a system notice about a lapse in government funding and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for status updates. The page also shows a revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:55:07.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Show glossary is now available, and the study record dates include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous entries Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:58:16.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page shows a minor revision update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:38:50.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Locations sections were added, listing study sites in Massachusetts, Texas, Lower Silesian Voivodeship, and Ulster; the revision tag updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T08:57:53.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 replacing Revision: v3.3.1; no other study content, eligibility criteria, contacts, locations, or outcomes appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:50:00.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1; this appears to be a versioning change that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:27:38.000Z thumbnail image

Stay in the know with updates to PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.